A feeder-free culture using autogeneic conditioned medium for undifferentiated growth of human embryonic stem cells: Comparative expression profiles of mRNAs, microRNAs and proteins among different feeders and conditioned media
© Tsai et al; licensee BioMed Central Ltd. 2010
Received: 15 January 2010
Accepted: 12 October 2010
Published: 12 October 2010
Human embryonic stem (hES) cell lines were derived from the inner cell mass of human blastocysts, and were cultured on mouse embryonic fibroblast (MEF) feeder to maintain undifferentiated growth, extensive renewal capacity, and pluripotency. The hES-T3 cell line with normal female karyotype was previously used to differentiate into autogeneic fibroblast-like cells (T3HDF) as feeder to support the undifferentiated growth of hES-T3 cells (T3/HDF) for 14 passages.
A feeder-free culture on Matrigel in hES medium conditioned by the autogeneic feeder cells (T3HDF) was established to maintain the undifferentiated growth of hES-T3 cells (T3/CMHDF) for 8 passages in this investigation. The gene expression profiles of mRNAs, microRNAs and proteins between the undifferentiated T3/HDF and T3/CMHDF cells were shown to be very similar, and their expression profiles were also found to be similar to those of T3/MEF and T3/CMMEF cells grown on MEF feeder and feeder-free Matrigel in MEF-conditioned medium, respectively. The undifferentiated state of T3/HDF and T3/CMHDF as well as T3/MEF andT3/CMMEF cells was evidenced by the very high expression levels of "stemness" genes and low expression levels of differentiation markers of ectoderm, mesoderm and endoderm in addition to the strong staining of OCT4 and NANOG.
The T3HDF feeder and T3HDF-conditioned medium were able to support the undifferentiated growth of hES cells, and they would be useful for drug development and toxicity testing in addition to the reduced risks of xenogeneic pathogens when used for medical applications such as cell therapies.
Human embryonic stem (hES) cell lines were derived from the inner cell mass of human blastocysts, and were cultured on mouse embryonic fibroblast (MEF) feeder to maintain undifferentiated growth, extensive renewal capacity, and pluripotency, including the ability to form teratomas in SCID mice and embryoid bodies in vitro. The hES cells were later shown to be able to retain their fundamental characteristics by culturing on Matrigel in MEF-conditioned medium, and this feeder-free culture system is suitable for scale up production of undifferentiated hES cells . In addition to their contribution to basic research such as stem cell biology and early human development, hES cells have great potential as source of cells for therapeutic uses. In order to reduce the risks of cross-transfer of pathogens from xenogeneic feeder or conditioned medium, an autogeneic feeder cell system, comprising fibroblast-like cells differentiated from hES cells, was developed to grow undifferentiated and pluripotent hES cells for their medical applications . A feeder-free culture using medium conditioned by autogeneic feeder cells is desirable in order to use hES cells as tools for drug development and toxicity testing.
In our laboratory, five hES cell lines had been derived , and one line hES-T3 with normal female karyotype was used to establish autogeneic feeder cells with capacity to support the growth of undifferentiated hES cells . In this investigation, a feeder-free culture on Matrigel in medium conditioned by these autogeneic feeder cells was established to maintain the undifferentiated growth of hES cells, and the gene expression profiles of mRNAs, microRNAs (miRNAs) and proteins were further shown to be very similar between the undifferentiated hES cells grown on autogeneic feeder and its conditioned medium, as well as MEF feeder and MEF-conditioned medium.
Undifferentiated growth of hES cells on MEF feeder and MEF-conditioned medium
Human embryonic stem cell line hES-T3, which is one of the five hES cell lines derived in our laboratory with institutional review board approval and informed consent by couples undergoing IFV treatment in Taiwan , exhibits normal female karyotype (46, XX), and it has been continuously cultured on mitomycin C (10 ug/ml) mitotically inactivated MEF feeder in hES medium under 5% CO2 at 37°C and underwent freezing/thawing processes. The hES culture medium consisted of DMEM/F12 (1:1, GIBCO) supplemented with 20% KSR (Invitrogen), 1% non-essential amino acids, 1 mM L-glutamine, 0.1 mM β-mercaptoethanol, and 4 ng/ml human basic fibroblast growth factor (bFGF; Life Technologies). Routine passages of hES-T3 cells every 5-7 days were done with collagenase (type IV, 1 mg/ml, Invitrogen) treatment and mechanical scrape [4, 5]. The cryopreserved stock of hES-T3 cells (36 passages) were continuously maintained on MEF feeder for additional 14 passages, and these the hES-T3 cells were designated as T3/MEF .
The MEF cells were cultured in MEF medium overnight, and the mitotically inactivated MEF cells were maintained in hES medium containing 4 ng/ml bFGF. After 24 h, the MEF-conditioned medium was collected and filtered through 0.2 um membrane (PN4612, Pall Life Sciences) as previously described . The culture dish was coated with Matrigel diluted with DMEM/F12 (1:30) overnight at 4°C. The cryopreserved stock of hES-T3 cells (36 passages) were continuously maintained on feeder-free Matrigel-coated dish in MEF-conditioned medium (with additional 4 ng/ml bFGF) for 12 passages, and these hES-T3 cells were designated as T3/CMMEF .
Establishment of human hES-T3 differentiated fibroblast-like cells
Autogeneic feeder cells with capacity to support the growth of undifferentiated hES cells were established according to the previously published procedure . hES-T3 (passage 19) cells were transferred into feeder-free and noncoated plate (10 cm) in DMEM supplemented with 10% FBS (GIBCO) under 5% CO2 at 37°C. After 10 days, cells appeared as fibroblast-like morphology, that is, flat cells with elongated nucleus and branching pseudopodia. These hES-T3 differentiated fibroblast-like cells are designated as T3HDF. The expression of transcription factors OCT4, SOX2 and NANOG, which were highly expressed in T3/MEF cells, was shown to be down-regulated in differentiated T3HDF cells. The expression profiles of mRNAs and miRNAs between T3/MEF and T3HDF cells were also found to very different . These T3HDF cells were passaged using trypsin (0.05%, GIBCO) every 4 days or cryopreserved.
Undifferentiated growth of hES cells on T3HDF feeder and T3HDF-conditioned medium
The differentiated fibroblast-like T3HDF cells (passage 8) were inactivated using mitomycin C (10 ug/ml) and used as autogeneic feeder layer in hES medium to maintain the continuously undifferentiated growth of hES-T3 cells (36 passages on MEF) for additional 14 passages . These hES-T3 cells grown on T3HDF feeder were designated as T3/HDF.
The T3HDF cells were cultured in DMEM medium overnight, and the mitotically inactivated T3HDF were maintained in hES medium containing 4 ng/ml bFGF. After 24 h, the T3HDF-conditioned medium was collected and filtered through 0.2 um membrane . The culture dish was coated with Matrigel diluted with DMEM/F12 (1:30) overnight at 4°C. The hES-T3 cells (36 passages on MEF feeder) were first grown on T3HDF feeder for 4 passages and then on Matrigel in T3HDF-conditioned medium for additional 4 passages. The hES-T3 cells grown on feeder-free Matrigel-coated dish in T3HDF-conditioned medium (with additional 4 ng/ml bFGF) were designated as T3/CMHDF
Staining of OCT4 and NANOG
T3/HDF and T3/CMHDF, as well as T3/MEF and T3/CMMEF, colonies were fixed by 4% paraformaldehyde and permeabilized using 0.5% Triton X-100 in the culture dishes. The immunostaining with rabbit polyclonal antibodies against human OCT4 (POU5F1) and NANOG (Santa Cruz Biotechnology) were detected with goat anti-rabbit IgG as described previously [5, 6].
Extraction of total RNAs
Total RNAs from approximately 1 × 106 cells of T3/HDF and T3/CMHDF on 10 cm plate were extracted using TRIZOL reagent, and the same total RNAs from each sample were used for both mRNA microarray analysis and miRNA quantification.
mRNA microarray analysis
The mRNA profilings of T3/HDF and T3/CMHDF cells were analyzed using Affymetrix Human Genome U133 plus 2.0 GeneChip according to the Manufacturer's protocols (Santa Clara, CA, USA, http://www.affymetrix.com) by the Microarray Core Facility of National Research Program for Genomic Medicine of National Science Council in Taiwan as previously described [5, 6]. This Affymetrix GeneChip contains 54,675 probe sets to analyze the expression levels of 47,400 transcripts and variants, including 38,500 well-characterized human genes. GeneChips from the hybridization experiments were read by the Affymetrix GeneChip scanner 3000, and raw data were processed using Affymetrix GeneChip Operating Software MAS5.0 and its default analysis parameters. The raw data were also analyzed by GeneSpring GX software version 7.3.1 (Silicon Genetics, Redwood City, CA, USA, http://www.chem.agilent.com). The correlation coefficients of gene probes expressed between any two samples were calculated from the normalized values by using GeneChip-Robust Multiarray Average (GC-RMA) algorithm. It may be noted that Affymetrix GeneChip expression analysis can be used as a stand-alone quantitative comparison, since the correlation between Affymetrix GeneChip results and TagMan RT-qPCR results was shown in a good linearity of R2 = 0.95 by the MicroArray Quality Control Study, a collaborative effort of 137 scientists led by the US-FDA [7, 8]. A hierarchical clustering and principle component analysis (PCA) of the eight Affymetrix GeneChip data from duplicates of four populations of hES cells were also performed in order to check the quality of microarray results.
Analyses of signaling pathways and GO process networks
The abundantly (more than 3-folds of overall mean) expressed mRNAs of T3/HDF and T3/CMHD, as well as T3/MEF and T3/CMMEF, cells were analyzed for signaling pathways and GO process networks by using MetaCore Analytical Suite (GeneGo Inc., St Joseph, MI, USA) as previously described . The MetaCore includes a curated database of human protein interaction and metabolism, and thus it is useful for analyzing a cluster of genes in the context of regulatory network and signaling pathways.
Quantification of miRNAs
The expression levels of 365 human miRNAs from T3/HDF and T3/CMHD cells were determined using the TaqMan MicroRNA Assays (Applied Biosystems, Foster City, California, USA, http://www.appliedbiosystems.com) [9, 10]. The detailed procedure for miRNA quantification was previously described [5, 6]. In brief, TagMan MicroRNA Assays include two steps: stem loop RT followed by real-time PCR. (90 ng/Rx, with 24-multiplex primers) Each 10 ul RT reaction that includes 90 ng total RNA, 50 nM stem-loop RT primers, 1× RT buffer, 1.25 mM each of dNTPs, 0.25 U/ul RNase inhibitor, and 10 U/ul MultiScribe Reverse Transcriptase was incubated in the PTC-225 Peltier Thermal Cycler (MJ Research, Watertown, Massachusetts, USA) for 30 min each at 16°C and at 42°C, followed by 5 min at 85°C, and then held at 4°C. RT products were diluted twenty times with H2O prior to setting up PCR reaction. Real-time PCR for each miRNA was carried out in triplicates, and each 10 ul reaction mixture included 2 ul of diluted RT product, 5 ul of 2× TagMan Universal PCR Master Mix and 0.2 uM TagMan probe, respectively. The reaction was incubated in an Applied Biosystems 7900HT Sequence Detection System at 95°C for 10 min, followed by 40 cycles of 95°C for 15 sec and 60°C for 1 min. The threshold cycle (Ct) is defined as the fraction cycle number at which the fluorescence exceeds the fixed threshold of 0.2. Total RNA input was normalized based on the Ct values of the TagMan U6 snRNA assay as an endogenous control. The fold change was calculated as 2-ΔCT × K, where -ΔCT = -[CTmiRNA-CTU6 snRNA] and K is a constant.
2D-gel analysis of proteins
Approximately 1 × 106 hES cells on 10 cm plate were washed twice each with 1× PBS and cell wash buffer, and then lyzed using NP40 lysis buffer. 1 mL ice-cold acetone/11% w/v trichloroacetic acid (TCA)/20 mM DTT was added per 0.1 mL solubilised sample and incubated for a minimum of 30 min at -20°C. The precipitate was pelleted by centrifugation (12000 rpm for 10 min at 4°C), washed twice with 1 mL cold acetone containing 20 mM DTT, and then air-dried to remove residual acetone. The resulting protein pellet was then resolubilised in the appropriate rehydration buffer (7 M urea, 2 M thiourea, 2% CHAPS, 0.5% IPG buffer, 20 mM DTT). The concentration of proteins in the sample was measured by the Bradford method.
Isoelectricfocusing was performed using an Ettan IPGphor II (Amersham Biosciences). 13 cm Immobiline DryStrips (pH 3-10 NL) were rehydrated overnight for 12 h at room temperature in 250 uL rehydration buffer containing 7 M urea, 2 M thiourea, 2% w/v CHAPS, 20 mM DTT, 0.5% IPG buffer and a trace of bromophenol blue. The protein sample (about 100 ug) was mixed in 100 uL sample buffer containing 7 M urea, 2 M thiourea, 2% CHAPS, 0.5% IPG buffer pH 3-10 NL, 100 mM DeStreak reagent (Amersham biosciences) and a trace of bromophenol blue. Samples were cup-loaded near the anode of the IPG strips using Ettan IPGphor cup-loading (Amersham Biosciences) according to the manufacturer's protocol. Protein focusing was achieved using the following IEF parameters: 300 V, step and hold, 3 h; 600 V, gradient, 1 h; 1000 V, gradient, 1 h; 8000 V, gradient, 1.5 h; 8000 V, step and hold for 3 h, giving a total of 16000 Vh.
After focusing, the strips were removed immediately and equilibrated by gentle shaking for 15 min in 10 mL equilibration buffer (50 mM Tris-base, pH = 8.8, 6 M urea, 30% v/v glycerol, 0.2% w/v SDS and 1% w/v DTT), followed by 10 mL of the same solution containing 2.5% w/v iodoacetamine instead of DTT for 15 min. The second dimension was performed by SDS-polyacrylamide gel electrophoresis (PAGE) on a 12% w/v separation gel using the Hoefer SE 600 vertical chambers. First dimension IPG gel strips were cut and placed on top of the second dimension vertical gels (16 × 18 × 0.01 cm) and sealed in place with boiling 0.5% agarose in running buffer, containing 0.025 M Tris base, 0.192 M glycine, 0.1% w/v SDS, pH 8.3. The second dimension separation was performed sequentially with a constant voltage of 70 V for 0.5 h, and 120 V for 12 h. After SDS-PAGE, the separated gels were visualized by silver staining. The similarities of protein spots on scanned images were analyzed using ImageMaster 2DE platinum software version 5.0 (Amersham Biosciences).
Characterization of undifferentiated T3/HDF and T3/CMHDF cells
The hES-T3 cells (36 passages on MEF feeder) were cultured on T3HDF feeder in hES medium (containing 4 ng/ml bFGF) (T3/HDF) and feeder-free Matrigel in T3HDF-conditioned medium with additional 4 ng/ml bFGF (T3/CMHDF) for 14 and 8 passages, respectively. The T3/HDF and T3/CMHDF, as well as T3/MEF and T3/CMMEF, cells were stained positively for OCT4 and NANOG (Additional file 1: Fig. S1).
Expression profiling of mRNAs
The expression levels of "stemness" genes and differentiation markers.
A. 21"stemness" genes
Teratocarcinoma-derived growth factor 1, CRIPTO
ASH1L (Drosophila), hypothetical protein, 2969aa
Similar to POU domain Class 5 transcription factor 1
Developmental pluripotency associated 4, 294aa
Ubiquitin specific protease 44
Sal-like 4 (Drosophila), zinc finger protein
POU domain Class 5 Transcription Factor 1,OCT4, 360aa
Leukocyte cell derived chemotaxin 1
POU domain, OCT4-related intron-less gene, 359aa
Developmental pluripotency associated 2, 221aa
Cordon-bleu homolog (mouse)
Zinc finger protein 208
UDP-glucose pyrophosphorylase 2
Acid sphingomyelinase-like phosphodiesterase
Microtubule-associated protein 7
Ubiquitin specific protease 28
BUB1 budding (yeast), human spindle check point kinase
Telomerase reverse transcriptase
B. 9 differentiation markers
microtubule-associated protein 2
neurogenic differentiation 1
msh homeobox 1
collagen, type I, alpha 1
H19, imprinted maternally untranslated mRNA
Signaling pathways and GO process networks
The top 10 GeneGo canonical pathway maps of T3/HDF, T3/CMHDF, T3/MEF and T3/CMMEF cells are shown in Fig. 2B. The number 1 pathway of their 650 common genes is involved in development, that is, the role of Activin A in cell differentiation and proliferation, and another three of top 10 pathways are involved in cell adhesion (gap junctions, tight junctions and plasmin signaling). It may be further noted that the number 1 GO process network of their 650 common genes is also involved in cell adhesion (cell junctions), and four of top 10 GO process networks are involved in development (three neurogenesis) (Additional file 6: Fig. S3). The first two of the top 10 pathways of the 1256 similar genes among these four cell populations are cell adhesion (gap junctions and tight junctions) and the third pathway is regulation of metabolism (bile acids, glucose and lipid). The top three process networks of these 1256 similar genes are development (two neurogenesis and one hedgehog signaling). As to the differentially altered pathways of unique genes, the top three pathways in T3/HDF cells are cell adhesion (tight junction), immune response (neuroendocrine- macrophage connector) and signaling transduction (PKA signaling). The top three pathways in T3/CMHDF cells are development (role of activin A in cell differentiation and proliferation), cytoskeleton remodeling (neurofilament) and immune response (neuroendocrine-macropphage connector). The top three pathways in T3/MEF cells are cell adhesion (gap junctions), cytoskeleton remodeling (neurofilament) and regulation of metabolism (bile acids, glucose and lipid). The top two pathways in T3/CMMEF cells are cytoskeleton remodeling (neurofilament) and cell adhesion (tight junctions).
Expression profiling of miRNAs
The expression levels and fold-changes of 35/31 most abundantly expressed miRNAs.
Protein patterns of 2D-gel analysis
Similarities among expressions of protein spots and mRNAs of T3/HDF, T3/CMHDF, T3/MEF and T3/CMMEF cells.
* Corr. coeff. (r)
The hES-T3 cell line with normal female karyotype, one of five hES cell lines derived in our laboratory , was used to differentiate into autogeneic fibroblast-like cells (T3HDF) as feeder to support the undifferentiated growth of hES-T3 cells (T3/HDF) for 14 passages  according to the previously published procedure . Stojkovic et al.  reported that the hES cells cultured on autogeneic feeder and Matrigel in the presence of autogeneic conditioned medium for 44 and 14 passages, respectively, still maintained normal karyotype and expressed hES markers such as TRA-1-60, SSEA-4 and GTCM-2. This autogeneic feeder system was further shown to permit continuous growth of pluripotent hES cells as demonstrated by the formation of teratoma in SCID mice and in vitro differentiation. In this investigation, a feeder-free culture on Matrigel in medium conditioned by these autogeneic feeder cells (T3HDF) was established to maintain the undifferentiated growth of hES-T3 cells (T3/CMHDF) for 8 passages. The gene expression profiles of mRNAs, miRNAs and proteins among the undifferentiated T3/HDF, T3/CMHDF, T3/MEF and T3/CMMEF cells were shown to be very similar. In recent years, many improvements on standard MEF culture have been reported to develop xeno-free culture systems of hES cells for future clinical applications [11–17]. To our knowledge, this investigation is the first report that systematically compared and demonstrated the similar expression profiles of mRNAs, miRNAs and proteins among different feeders and conditioned media. However, many more passages (i.e. 20) of the undifferentiated growth of hES-T3 cells on autogeneic T3HDF feeder and feeder-free on Matrigel in the T3HDF conditioned medium should be carried out and their differentiation capacities (pluripotencies) should also be demonstrated using formation of embryoid bodies in vitro and/or teratoma in SCID mice in the future investigation.
The abundantly expressed genes of T3/HDF, T3/CMHD, T3/MEF and T3/CMMEF cells were found to play prominent roles in signaling pathways and GO process networks. Three of the top 10 GeneGo canonical pathway maps and four of the top 10 GO process networks of the common and/or similar genes among these four cell populations were involved in development. Their number 1 pathway was the role of Activin A in cell differentiation and proliferation, and the importance of Activin/Nodal/TGFβ family members in the maintenance of pluripotency of hES cells is widely established [18–20]. Among these common and/or similar genes, cell adhesion was also involved in three of the top 10 GeneGo canonical pathway maps and two of the top 10 GO process networks. However, the abundantly differentially expressed genes of T3/HDF and T3/MEF cells grown on feeder appeared to play important roles in cell adhesion (tight junctions and gap junctions), while those of T3/CMHDF and T3/CMMEF cells grown on feeder-free Matrigel in their conditioned medium had important effects on cytoskeleton remodeling. The fact that the many more genes were found to be expressed abundantly in T3/HDF and T3/CMHDF cells compared with T3/MEF and T3/CMMEF cells may indicate that autogeneic feeder cells and their conditioned medium were better suitable for the undifferentiated growth of hES cells than those of MEF. It is also of interest that galanin and galectin 1 were the most abundantly expressed genes in T3/HDF and T3/CMHDF cells, respectively. Galanin is a neuropeptide with important central nervous system actions (in particular its proposed role in Alzheimer's disease) . The galectin-1 protein has been reported to have many diverse biological functions . The specific roles of galanin and galectin-1 proteins in T3/HDF and T3/CMHDF cells remain to be investigated.
The miRNAs, a class of noncoding small RNAs that participate in the post-transcriptional regulation of gene expression, have been shown to play key roles in maintenance of the undifferentiated and pluripotent state as well as differentiation and lineage commitment of embryonic stem cells . As demonstrated previously [24–27], the miR-302/367 cluster on chromosome 4 and miR-371/372/373 cluster on chromosome 19 were extremely abundantly expressed in undifferentiated hES-T3 cells grown on T3HDF feeder (T3/HDF) and feeder-free Matrigel in T3HDF-conditioned medium (T3/CMHDF), as well as MEF feeder (T3/MEF) and feeder-free Matrigel in MEF-conditioned medium (T3/CMMEF). The members of these two clusters share a consensus seed sequence and their targeted genes have overlapping functions [5, 26, 27]. The extremely abundant expression of hES cell-specific miR-302/367 and miR-371/372/373 clusters also indicated the very high proportion of undifferentiated hES cells present in these four cell populations. Recently, we reported that the expression of hES cell-specific miRNAs miR-302 d, miR-372 and miR-367 and miR-200c, as well as miR-199a, were strongly up-regulated by activin A . It should also be noted that the large variations between the miRNA expression levels of T3/HDF and T3/CMHDF cells and those of T3/MEF and T3/CMMEF cells were most likely due to the different platforms (containing 365 and 250 miRNAs, respectively) used.
The soluble proteins of T3/HDF, T3/CMHDF, T3/MEF and T3/CMMEF cells were separated on 2D-gels, and their patterns of protein spots appeared to be very similar. The extents of protein similarities among these four cell populations appeared to be smaller than those of mRNAs, and these results may be due to the more variations of proteins because of post-translational modifications and/or technical variations among different 2D-gels. In the future studies, the proteins, which will be extracted using the classic RIPA buffer (Pierce) to obtain more proteins from the cells, from two different cell populations will be first labeled separately with Cy3 and Cy5 dyes, and then pooled together for comparison on a single 2D-gel in order to detect more accurately their similarities and differences. The different protein spots among these four cell populations will be identified using tandem mass spectrometry. It will be of interest if these different proteins were found to be in common with their unique genes detected in mRNA profiling. Although the proteomes of hES cells have previously been reported [28, 29], the quantitative comparison between proteomes of hES-T3 cells and their differentiated fibroblasts (T3HDF) is being investigated in our laboratory. Our preliminary results (S.S.-L.Li, et al. unpublished) indicate that many of abundantly differentially expressed proteins are found to be heterogeneous nuclear ribonucleoproteins (hnRNPs). This finding of abundant hnRNP proteins is consistent with the facts that hES cells exhibit high ratio of nucleus to cytoplasm  and the hnRNP proteins are among the most abundant proteins in nucleus . As to the proteome of T3DF cells, the abundantly differentially expressed proteins include several glycolytic enzymes such as L-lactate dehydrogenase A(M), and this observation is also consistent with the more anaerobic metabolism of fibroblasts.
The hES-T3 cell line was previously used to differentiate into autogeneic fibroblast-like cells (T3HDF) as feeder to support the undifferentiated growth of hES-T3 cells (T3/HDF). In this investigation, a feeder-free culture on Matrigel in hES medium conditioned by these autogeneic feeder cells (T3HDF) was established to maintain the undifferentiated growth of hES-T3 cells (T3/CMHDF). The gene expression profiles of mRNAs, microRNAs and proteins between the undifferentiated T3/HDF and T3/CMHDF cells were shown to be very similar, and their expression profiles were also found to be similar to those of T3/MEF and T3/CMMEF cells grown on MEF feeder and feeder-free Matrigel in MEF-conditioned medium, respectively. The undifferentiated state of T3/HDF and T3/CMHDF, as well as T3/MEF and T3/CMMEF, cells was evidenced by the very high expression levels of "stemness" genes, as well as hES cell-specific miR-302/367 and miR-371/372/373 clusters, and low expression levels of differentiation markers of ectoderm, mesoderm and endoderm in addition to the strong staining of OCT4 and NANOG. Thus, the T3HDF feeder and T3HDF-conditioned medium were able to support the undifferentiated growth of hES cells, and they would be useful for drug development and toxicity testing in addition to the reduced risks of xenogeneic pathogens when used for medical applications such as cell therapies.
Database and accession number
The original data obtained from Affymetrix human genome U133 plus 2.0 GeneChip have been deposited to NCBI database, and the GEO series number is GSE19902.
ZYT, MS, Research Assistant; SS, Ph.D., Assistant Professor; S-LY, Ph.D., Associate Professor; CHC, MS, Research Assistant; SS-LL, Ph.D., Chair Professor.
human embryonic stem cells
mouse embryonic fibroblasts
hES-T3 cells grown on MEF feeder
hES-T3 cells grown on feeder-free Matrigel in MEF-conditioned medium
hES-T3 differentiated fibroblast-like cells
hES-T3 cells grown on T3HDF feeder
hES-T3 cells grown on feeder-free Matrigel in T3HDF-conditioned medium.
We thank the technical assistance by the research assistants at Microarray Core Facility of National Research Program for Genomic Medicine of National Science Council in Taiwan. We also thank the reviewers' helpful comments and suggestions. This investigation was supported in part by Center of Excellence for Environmental Medicine, Kaohsiung Medical University and a grant (NSC-97-3112-B-037-002) from National Science Council of Taiwan.
- Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM: Embryonic stem cell lines derived from human blastocysts. Science. 1998, 282 (5391): 1145-1147. 10.1126/science.282.5391.1145.View ArticlePubMed
- Xu C, Inokuma MS, Denham J, Golds K, Kundu P, Gold JD, Carpenter MK: Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol. 2001, 19 (10): 971-974. 10.1038/nbt1001-971.View ArticlePubMed
- Stojkovic P, Lako M, Stewart R, Przyborski S, Armstrong L, Evans J, Murdoch A, Strachan T, Stojkovic M: An autogeneic feeder cell system that efficiently supports growth of undifferentiated human embryonic stem cells. Stem Cells. 2005, 23 (3): 306-314. 10.1634/stemcells.2004-0137.View ArticlePubMed
- Li SS, Liu YH, Tseng CN, Chung TL, Lee TY, Singh S: Characterization and gene expression profiling of five new human embryonic stem cell lines derived in Taiwan. Stem Cells Dev. 2006, 15 (4): 532-555. 10.1089/scd.2006.15.532.View ArticlePubMed
- Li SS, Yu SL, Kao LP, Tsai ZY, Singh S, Chen BZ, Ho BC, Liu YH, Yang PC: Target identification of microRNAs expressed highly in human embryonic stem cells. J Cell Biochem. 2009, 106 (6): 1020-1030. 10.1002/jcb.22084.View ArticlePubMed
- Tsai ZY, Singh S, Yu SL, Kao LP, Chen BZ, Ho BC, Yang PC, Li SS: Identification of microRNAs regulated by activin A in human embryonic stem cells. J Cell Biochem. 2010, 109 (1): 93-102.PubMed
- Canales RD, Luo Y, Willey JC, Austermiller B, Barbacioru CC, Boysen C, Hunkapiller K, Jensen RV, Knight CR, Lee KY: Evaluation of DNA microarray results with quantitative gene expression platforms. Nat Biotechnol. 2006, 24 (9): 1115-1122. 10.1038/nbt1236.View ArticlePubMed
- Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC, Collins PJ, de Longueville F, Kawasaki ES, Lee KY: The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol. 2006, 24 (9): 1151-1161. 10.1038/nbt1239.View ArticlePubMed
- Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR: Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005, 33 (20): e179-10.1093/nar/gni178.PubMed CentralView ArticlePubMed
- Liang Y, Ridzon D, Wong L, Chen C: Characterization of microRNA expression profiles in normal human tissues. BMC Genomics. 2007, 8: 166-10.1186/1471-2164-8-166.PubMed CentralView ArticlePubMed
- Xu C, Jiang J, Sottile V, McWhir J, Lebkowski J, Carpenter MK: Immortalized fibroblast-like cells derived from human embryonic stem cells support undifferentiated cell growth. Stem Cells. 2004, 22 (6): 972-980. 10.1634/stemcells.22-6-972.View ArticlePubMed
- Yoo SJ, Yoon BS, Kim JM, Song JM, Roh S, You S, Yoon HS: Efficient culture system for human embryonic stem cells using autologous human embryonic stem cell-derived feeder cells. Exp Mol Med. 2005, 37 (5): 399-407.View ArticlePubMed
- Choo A, Ngo AS, Ding V, Oh S, Kiang LS: Autogeneic feeders for the culture of undifferentiated human embryonic stem cells in feeder and feeder-free conditions. Methods Cell Biol. 2008, 86: 15-28. full_text.View ArticlePubMed
- Gonzalez R, Loring JF, Snyder EY: Preparation of autogenic human feeder cells for growth of human embryonic stem cells. Curr Protoc Stem Cell Biol. 2008, Chapter 1: Unit 1C 5 1-1C 5 15
- Chen HF, Chuang CY, Shieh YK, Chang HW, Ho HN, Kuo HC: Novel autogenic feeders derived from human embryonic stem cells (hESCs) support an undifferentiated status of hESCs in xeno-free culture conditions. Hum Reprod. 2009, 24 (5): 1114-1125. 10.1093/humrep/dep003.View ArticlePubMed
- Fu X, Toh WS, Liu H, Lu K, Li M, Hande MP, Cao T: Autologous Feeder Cells from Embryoid Body Outgrowth Support the Long-Term Growth of Human Embryonic Stem Cells More Effectively than Those from Direct Differentiation. Tissue Eng Part C Methods. 2010, 16 (4): 719-733. 10.1089/ten.tec.2009.0360.View ArticlePubMed
- Mallon BS, Park KY, Chen KG, Hamilton RS, McKay RD: Toward xeno-free culture of human embryonic stem cells. J Biochem Cell Biol. 2006, 38 (7): 1063-1075. 10.1016/j.biocel.2005.12.014.View Article
- James D, Levine AJ, Besser D, Hemmati-Brivanlou A: TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development. 2005, 132 (6): 1273-1282. 10.1242/dev.01706.View ArticlePubMed
- Beattie GM, Lopez AD, Bucay N, Hinton A, Firpo MT, King CC, Hayek A: Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells. 2005, 23 (4): 489-495. 10.1634/stemcells.2004-0279.View ArticlePubMed
- Vallier L, Alexander M, Pedersen RA: Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J Cell Sci. 2005, 118 (Pt 19): 4495-4509. 10.1242/jcs.02553.View ArticlePubMed
- Lundström L, Elmquist A, Bartfai T, Langel U: Galanin and its receptors in neurological disorders. Neuromolecular Med. 2005, 7 (1-2): 157-180. 10.1385/NMM:7:1-2:157.View ArticlePubMed
- Camby I, Le Mercier M, Lefranc F, Kiss R: Galectin-1: a small protein with major functions. Glycobiology. 2006, 16 (11): 137R-157R. 10.1093/glycob/cwl025.View ArticlePubMed
- Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004, 116 (2): 281-297. 10.1016/S0092-8674(04)00045-5.View ArticlePubMed
- Suh MR, Lee Y, Kim JY, Kim SK, Moon SH, Lee JY, Cha KY, Chung HM, Yoon HS, Moon SY: Human embryonic stem cells express a unique set of microRNAs. Dev Biol. 2004, 270 (2): 488-498. 10.1016/j.ydbio.2004.02.019.View ArticlePubMed
- Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M: A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007, 129 (7): 1401-1414. 10.1016/j.cell.2007.04.040.PubMed CentralView ArticlePubMed
- Laurent LC, Chen J, Ulitsky I, Mueller FJ, Lu C, Shamir R, Fan JB, Loring JF: Comprehensive microRNA profiling reveals a unique human embryonic stem cell signature dominated by a single seed sequence. Stem Cells. 2008, 26 (6): 1506-1516. 10.1634/stemcells.2007-1081.View ArticlePubMed
- Ren J, Jin P, Wang E, Marincola FM, Stroncek DF: MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells. J Transl Med. 2009, 7: 20-10.1186/1479-5876-7-20.PubMed CentralView ArticlePubMed
- Baharvand H, Hajheidari M, Ashtiani SK, Salekdeh GH: Proteomic signature of human embryonic stem cells. Proteomics. 2006, 6 (12): 3544-3549. 10.1002/pmic.200500844.View ArticlePubMed
- Hoof DV, Passier R, Oostwaard DWV, Pinkse MWH, Heck AJR, Mummery CL, Krijgsveld : A quest for human and mouse embryonic stem cell-specific proteins. Mol Cell Proteomics. 2006, 5 (7): 1261-1273. 10.1074/mcp.M500405-MCP200.View ArticlePubMed
- Dreyfuss G, Matunis MJ, Pinol-Roma S, Burd CG: hnRNP proteins and the biogenesis of mRNA. Ann Rev Biochem. 1993, 62: 289-321. 10.1146/annurev.bi.62.070193.001445.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.